This content is in French.
Ensitrelvir in mild to moderate Covid-19
14 février 2024
In this randomized, double-blind, placebo-controlled Phase 3 clinical trial, investigators evaluated the efficacy and safety of ensitrelvir in 1,821 patients with mild-to-moderate Covid-19. Patients…
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Hiroshi Yotsuyanagi et al. Efficacy and Safety of 5-Day Oral Ensitrelvir for Patients With Mild to Moderate COVID-19: The SCORPIO-SR Randomized Clinical Trial. JAMA Netw Open. 2024 Feb 5;7(2):e2354991.
View the sourceOther recent articles
Advanced hepatocellular carcinoma in Europe: a rapidly evolving treatment landscape
27 octobre 2026
Hepatocellular carcinoma in Europe: a shifting epidemiological landscape
27 octobre 2026
Neuromodulation for Neuropathic Pain: Which Techniques Offer the Greatest Relief?
23 octobre 2026